Spherical granules having core and their production
AssigneeTakeda Chemical Industries, Ltd.
InventorsTadashi Makino, Tetsuro Tabata, Shin-ichiro Hirai
Life of this patent
Estimating the term…
Abstract
The spherical granules having a core coated with spraying powder containing a drug and low substituted hydroxypropylcellulose, because of their excellent hardness, can be coated further evenly, (e.g. sustained release coating, gastric coating, enteric coating), and at the time the granules are excellent in disintegration.
Claims24
Spherical granules having a core coated with spraying powder containing a drug and low substituted hydroxypropylcellulose having an hydroxypropoxy content of about 4-20% and a mean particle diameter of not more than 200 .mu.m, wherein said spraying powder comprises about 20% to about 35% (w/w) of said low substituted hydroxypropylcellulose, wherein the drug is a drug for the central nervous system, and wherein the spherical granules pass through 12 mesh sieve but do not pass through 32 mesh sieve.
The spherical granules having a core according to claim wherein the mean particles of the hydroxypropylcellulose diameter is not more than 100 .mu.m.
Spherical granules having a core coated with spraying powder containing a drug and low substituted hydroxypropylcellulose having an hydroxypropoxy content of about 4-20% and a mean particle diameter of not more than 200 .mu.m, wherein said spraying powder comprises about 20% to about 35% (w/w) of said low substituted hydroxypropylcellulose, wherein the drug is a drug for the circulatory system, and wherein the spherical granules pass through 12 mesh sieve but do not pass through 32 mesh sieve.
Spherical granules having a core coated with spraying powder containing a drug and low substituted hydroxypropylcellulose having an hydroxypropoxy content of about 4-20% and a mean particle diameter of not more than 200 .mu.m, wherein said spraying powder comprises about 20% to about 35% (w/w) of said low substituted hydroxypropylcellulose, wherein the drug is a drug for the respiratory system, and wherein the spherical granules pass through 12 mesh sieve but do not pass through 32 mesh sieve.
Spherical granules having a core coated with spraying powder containing a drug and low substituted hydroxypropylcellulose having an hydroxypropoxy content of about 4-20% and a mean particle diameter of not more than 200 .mu.m, wherein said spraying powder comprises about 20% to about 35% (w/w) of said low substituted hydroxypropylcellulose, wherein the drug is an antibiotic or chemotherapeutic agent, and wherein the spherical granules pass through 12 mesh sieve but do not pass through 32 mesh sieve.
Spherical granules having a core coated with spraying powder containing a drug and low substituted hydroxypropylcellulose having an hydroxypropoxy content of about 4-20% and a mean particle diameter of not more than 200 .mu.m, wherein said spraying powder comprises about 20% to about 35% (w/w) of said low substituted hydroxypropylcellulose, wherein the drug is a drug for the metabolic system, and wherein the spherical granules pass through 12 mesh sieve but do not pass through 32 mesh sieve.
Spherical granules having a core coated with spraying powder containing a drug and low substituted hydroxypropylcellulose having an hydroxypropoxy content of about 4-20% and a mean particle diameter of not more than 200 .mu.m, wherein said spraying powder comprises about 20% to about 35% (w/w) of said Low substituted hydroxypropylcellulose, wherein the drug is a vitamin drug, and wherein the spherical granules pass through 12 mesh sieve but do not pass through 32 mesh sieve.
Dependencies are inferred from the claim text.